CASI Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CASI Shares Outstanding History and CASI YTD Return |
CASI Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CASI Shares Outstanding History and CASI YTD Return |
CASI Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-2.67% CAGR Mouse over chart for data details
|
CASI Stock Price Chart |
About CASI Pharmaceuticals Inc (New) |
CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, the U.S., and throughout the world.. In China, Co.'s first commercial product, EVOMELA® is approved for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The other core hematology/oncology assets in our pipeline include: CNCT19, which is being developed as a potential treatment for patients with hematological malignancies which express CD19 including, B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma. We show 53 historical shares outstanding datapoints in our CASI shares outstanding history coverage, used to compute CASI market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CASI market cap history over the course of time is important for investors interested in comparing CASI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CASI versus a peer is one thing; comparing CASI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CASI can fluctuate over the course of history. With this page we aim to empower investors researching CASI by allowing them to research the CASI market cap history. |
CASI Current Stock Quote |
Free CASI Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
CASI Share Performance |
Market Cap Peers |
CASI Pharmaceuticals (CASI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CASM Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.